Article
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
Chinese medical journal - 1 Jun 2011
Gao Fei, Wang Zan-Xin, Men Jian-Long, Ren Jing, Wei Min-Xin
Abstract excerpt
BACKGROUND: Aspirin is widely used in the secondary prevention of coronary artery diseases, including myocardial infarction, stroke, and vascular related deaths. However, the antiplatelet effect of aspirin appears to be variable and aspirin resistance (AR) is currently still controversial for Chinese patients. The aim of this study was to describe the prevalence of AR, and identify possible risk factors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
